Algernon Pharmaceuticals Inc. C.AGN

Alternate Symbol(s): AGNPF

Algernon Pharmaceuticals Inc. is a clinical-stage drug development company. The Company is focused on developing repurposed therapeutic drugs in the areas of non-alcoholic steatohepatitis (NASH), a type of liver disease, chronic kidney disease (CKD), inflammatory bowel disease (IBD), idiopathic pulmonary fibrosis (IPF) and chronic cough as well as advancing a stroke program using N, N-Dimethyltryptamine (DMT). The Company operates through two segments, which includes the development of repurposed therapeutic drugs in Canada and the facilitation of the Company’s lead drug candidates into off-label phase II clinical trials (humans) in Australia. The Company's pipeline includes NP-251 (Repirinast) and AP-188 (DMT). The Company, through its subsidiary, Algernon NeuroScience Inc., is developing AP-188 (DMT) as a potential treatment for stroke and traumatic brain injury (TBI) recovery. Its NP-251 is being developed as a potential treatment for kidney inflammation and fibrosis.

CSE:AGN - Post by User

Algernon Pharmaceuticals Inc.

Bullboard Posts

Comment by grosdavidon Apr 29, 2020 4:27pm

127 Views

Post# 30968333

RE:RE:At the close

Even in a situation of Halt, people can pass through their offers to buy or sell, no no trades are being made.

Level 2 indicates the actual transactions that were placed by investors to buy and sell at different levels. They are actual numbers as of 4pm today.

It is more as of an indication. Tomorrow will be different and possibly higher.

People placed bids in hope they allowed trading in the last minutes to pick up cheap shares. No shares we traded since 14:04.

David

Bullboard Posts

Understanding tax loss season and the “Santa Claus rally”